𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Markers and mediators of inflammation in neonatal lung disease

✍ Scribed by Ali Özdemir; Mark A. Brown; Wayne J. Morgan

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
178 KB
Volume
23
Category
Article
ISSN
8755-6863

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sleep, respiratory rate, and growth horm
Sleep, respiratory rate, and growth hormone in chronic neonatal lung disease
✍ Dominic Fitzgerald; Peter Van Asperen; Peter O'Leary; Peter Feddema; Garth Lesli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

This study assessed whether respiratory rates (RRs) correlate with urinary growth hormone (U-GH) excretion and sleep architecture in infants with chronic neonatal lung disease (CNLD) in early (1 month), middle (6 months), and late (10 months) infancy. Twenty-three preterm infants (CNLD = 16, control

Higher SaO2 in chronic neonatal lung dis
Higher SaO2 in chronic neonatal lung disease: Does it improve sleep?
✍ Dominic Fitzgerald; Peter Van Asperen; Garth Leslie; John Arnold; Colin Sullivan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Sleep fragmentation, decreased rapid eye movement (REM) sleep time, and REM sleep hypoxemia have been reported in infants with chronic neonatal lung disease (CNLD) in early infancy despite an awake hemoglobin oxygen saturation (SaO 2 ) >93%. Interestingly, higher inspired O 2 concentrations have bee

Effects of inhaled beclomethasone compar
Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease
✍ P. Groneck; B. Goetze-Speer; C.P. Speer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 × 500 µg) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf

Chronic lung disease following neonatal
Chronic lung disease following neonatal ventilation. I. Incidence in two geographically defined populations
✍ Alan C. Fenton; Gail Annich; Elizabeth Mason; Alfonso Solimano; David J. Field 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

The objective of this study was to compare the incidence of chronic lung disease following neonatal ventilation in two geographically defined populations. Prospective data collection was carried out over a 1 year period from March 11, 1990 to February 28, 1991 in the Trent Health Region (England) an

Early prediction of neonatal chronic lun
Early prediction of neonatal chronic lung disease: A comparison of three scoring methods
✍ Bradley A. Yoder; Muhammad U. Anwar; Reese H. Clark 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

A variety of postnatal therapies have been and will be evaluated for prevention or treatment of neonatal chronic lung disease (CLD). A simple method for early selection of the highest risk infants would optimize intervention trials. Our study compared a clinical scoring system for predicting neonata